Human Reproduction publishes full length, peer reviewed papers reporting original research, as well as opinions, debates, invited Editorials and Editorial Commentaries and concise clinical case reports of outstanding originality and importance.
Mini-reviews forming part of the ‘Developments in Reproductive Biology and Medicine’ series are also occasionally published. These articles aim to summarize concisely particularly important and rapidly-developing areas of reproductive medicine for which not enough has been published to enable more substantive reviews to be written. The majority of ‘Developments’ reviews will originate from the journal’s Associate Editors but uninvited contributions are also welcomed.
Papers should be within the recognized broad scope of human reproductive biology and reproductive medicine. This includes clinical science and medical aspects of reproductive physiology and pathology, reproductive endocrinology and endocrine therapies. It also includes andrology, contraception, early pregnancy, embryo development, ethical issues, fertilization, gametogenesis, genetic screening (first trimester) , genetic diagnosis (pre-implantation), gonadal function, implantation, infectious diseases, menstrual disorders, psycho-social issues, reproductive genetics, reproductive surgery, reproductive oncology, reproductive epidemiology, and stem cell research. Research which would be classified as clearly in the fields of obstetrics (here defined as being beyond the first trimester of pregnancy) or gynaecological oncology will not normally be published.
Studies using animal models will also be considered providing a clear relevance to the clinical science of human reproduction can be demonstrated.
Published on behalf of
Impact factor: 4.585
5-Yr impact factor: 4.619
Open access options for authors - visit Oxford Open